Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.80 |
| ▸ | LCK | P06239 | 1/20 | 0.80 |
| ▸ | LYN | P07948 | 1/20 | 0.80 |
| ▸ | SRC | P12931 | 1/20 | 0.80 |
| ▸ | CSK | P41240 | 1/20 | 0.80 |
| ▸ | BTK | Q06187 | 1/20 | 0.80 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.80 |
| ▸ | RAB9A | P51151 | 13/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 12/20 | 0.62 |
| ▸ | POLB | P06746 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | CASP3 | P42574 | 3/20 | 0.62 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.62 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3533832 | 0.79 | RAB9A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL3533833 | 0.79 | RAB9A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL5776769 | 0.77 | RAB9A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL5776766 | 0.77 | RAB9A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL17890297 | 0.76 | KMT2A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL6230728 | 0.76 | KMT2A (0.82) | ABL1LCKLYNSRCCSK | |
| SCHEMBL6230731 | 0.76 | KMT2A (0.82) | ABL1LCKLYNSRCCSK | |
| SCHEMBL17890294 | 0.76 | KMT2A (1.00) | ABL1LCKLYNSRCCSK | |
| SCHEMBL16007938 | 0.76 | GUSB (1.00) | RAB9AKDM4ENPC1ALDH1A1CASP3 | |
| SCHEMBL12553526 | 0.75 | TP53 (0.67) | LMNAKMT2AMEN1SMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2009-07-09 | — | — | US | disclosed |
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176773-A1 | Non-Peptidic Inhibitors of AKAP/PKA Interaction | PRKCH, AIP, PRKCE | ABL1 730/4885LCK 820/4885LYN 2921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.